#AHA26: Marea’s triglyceride candidate could have an edge in diabetic patients

Marea Therapeutics' investigational lipid-lowering medicine has shown further promise in cutting triglycerides in patients with dangerously high levels of these fatty molecules in their blood. It also didn’t increase patients’ blood sugar — and that could ...